Test article Week post vaccination H5N1 antigen for HAI test (GMT1)
Vietnam2 (clade 1) Indonesia3 (clade 2.1) Turkey4 (clade 2.2) Bar-h goose5 (clade 2.2) W.swan6 (clade 2.2) Anhui7 (clade 2.3)
VN/H5N2 LAIV (clade 1) 0 10.0 10.0 10.0 10.0 10.0 10.0
4 40.0 11.2 10.0 10.0 14.1 10.0
6 403.1 10.0 20.0 20.0 31.8 17.8
6/4 10.18 1.2 2.0 2.0 2.3 1.8
VN/H5N1-RG LAIV (clade 1) 0 10.0 10.0 10.0 10.0 10.0 10.0
4 50.4 11.2 10.0 10.0 22.5 10.0
6 285.1 35.6 14.1 14.1 127.0 17.8
6/4 5.7 3.2 1.4 1.4 5.6 1.8
t/T/H5N2 LAIV (clade 2.2) 0 10.0 10.0 10.0 10.0 10.0 10.0
4 127.0 10.0 12.6 14.1 10.0 10.0
6 508.0 44.9 127.0 113.1 40.0 22.5
6/4 4.01 4.5 10.1 8.0 4.0 2.3
PBS 0 10.0 10.0 10.0 10.0 10.0 10.0
4 10.0 10.0 10.0 10.0 10.0 10.0
6 10.0 10.0 10.0 10.0 10.0 10.0
6/4 1.0 1.0 1.0 1.0 1.0 1.0
Vaccination dose: 7.0 log10 ID50/ferret. Blood samples were collected at day 28 (week 4) and at day 42 (week 6) post immunization. 1Geometric mean titer; each group contained six animals; 2A/Vietnam/1203/04 (H5N1); 3A/Indonesia/5/05 (H5N1); 4A/turkey/Turkey/1/05 (H5N1); 5A/bar-headed goose/ Mongolia/1/2005 (H5N1); 6A/whooper swan/Mongolia/244/05 (H5N1); 7A/Anhui/1/05 (H5N1). 8A fourfold or greater rise in titer of antibodies against virus hemagglutinin in sera of ferrets between the first (week 4) and second sample (week 6) was considered as seroconversion.
Table 8: Immunogenicity of H5N2 LAIV candidates in experiments on ferrets.